Today is the first National PrEP Day — a new annual event dedicated to spreading information and awareness around HIV prevention.

It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

Health Minister Aaron Motsoaledi says the newly approved anti-HIV injection, Lenacapavir, is a game-changer. He has welcomed the health products regulator's (SAHPRA) decision to approve the ...

The drug, Lenacapavir, is the world's first injectable Pre-Exposure Prophylaxis (PrEP). According to the World Health ...

South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...

A University of Massachusetts Amherst public health researcher has received four grants totaling $17.9 million from the ...

Health Minister Dr Aaron Motsoaledi announced that the national rollout is expected to begin by March or April 2026, ...

There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...

The South African Health Products Regulatory Authority (SAHPRA) has announced the registration of lenacapavir, making South ...

Swiss study shows 60% of migrant HIV diagnoses are made post-arrival, challenging assumptions about when infections actually ...